Latest filing published 25 Jun 2026 for MapLight Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +57.1%Entry US$18.30 · Close at T+90 US$28.75
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
George Pavlov: trading record in brief
This profile gathers the share dealings of George Pavlov across 3 companies, led by Audience Inc, Ikanos Communications, Inc. and MapLight Therapeutics, Inc. Between 15 May 2012 and 23 June 2026, the trades on record add up to 37 filings.
On the market, this insider has only ever bought: 3 purchases, €374k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 2 option exercises. So far in 2026, the count stands at 3 purchases and no sales.
In size, the median ticket on the buying side is €151k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 3 purchases show a median change of +57.1%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.
On 25 June 2026 came the latest disclosure, a share grant in MapLight Therapeutics, Inc. The latest purchase dates back some time: it was published 261 days ago, on 20 February 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to George Pavlov
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,932 sharesVoting Common StockSEC:0001470798-26-000004:0
- 4,422 shares@ US$17.5717.6% of flowVoting Common StockSEC:0001470798-26-000002:1Canonical exit: 20 May 2026 (T+90)
- 9,920 shares@ US$17.8640.3% of flowVoting Common StockSEC:0001470798-26-000002:2Canonical exit: 21 May 2026 (T+90)
- 10,658 shares@ US$17.48100.0% of flowVoting Common StockSEC:0001470798-26-000002:0Canonical exit: 19 May 2026 (T+90)
- 8,449,449 sharesCommon StockSEC:0001219210-15-000164:1
- 9,335 sharesCommon StockSEC:0001219210-15-000164:0
- 4,613 shares@ US$2.51Common StockSEC:0000899243-15-000133:0
- 4,374,335 shares@ US$2.51Common StockSEC:0000899243-15-000133:1
- 2,307 shares0Common StockSEC:0001209191-15-051385:0
- 1,750 shares0Common StockSEC:0001219210-15-000138:0
- 19,280 shares0Common StockSEC:0001219210-15-000034:0
- 2,306 shares0Common StockSEC:0001209191-14-075344:0
- 7,000 shares0Common StockSEC:0001181431-14-022721:0
- 7,000 shares0Common StockSEC:0001181431-13-059677:0
- 7,000 shares0Common StockSEC:0001181431-13-032664:0
- 9,000 shares0Common StockSEC:0001181431-12-056434:0
- 51,368 sharesCommon StockSEC:0001181431-12-030558:6
- 161,386 sharesCommon StockSEC:0001181431-12-030558:7
- 159,893 sharesCommon StockSEC:0001181431-12-030558:5
- 75,303 sharesCommon StockSEC:0001181431-12-030558:8
- 147,402 sharesCommon StockSEC:0001181431-12-030558:9
- 5,513 sharesCommon StockSEC:0001181431-12-030558:10
- 1,771 sharesCommon StockSEC:0001181431-12-030558:11
- 385,950 sharesCommon StockSEC:0001181431-12-030558:0
- 123,992 sharesCommon StockSEC:0001181431-12-030558:1
25 of 37 declarations
